Skip to content
StockMarketAgent
Direct answer
ARM trades against a final fair-value range of $29.83-$71.24, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $29.8, high $71.2, with mid-point at $47.4.
Stock analysis

ARM fair value $30–$71

By StockMarketAgent.AI team· supervised by
Analysé: 2026-05-19Prochaine mise à jour: 2026-08-19Methodology v2.4Data cut-off: Quality gate: passSources: all material sources passed deterministic freshness/provenance gatesReview: automatedArchetype: Mature compounder
View archive
Cours
$223.15
▼ -175.74 (-78.75%)
Juste valeur
$47
$30–$71
Notation
Vendre
confidence 82/100
Potentiel de hausse
-78.8%
upside to fair value
Marge de sécurité
$40.30
MoS level · 15%
Capitalisation boursière
$237.4B
P/E fwd 73.0
Repli en anglaisFR
Affichage de la source anglaise pendant la traduction
Ce rapport n'a pas encore été traduit. Actualisez dans quelques minutes une fois que la file d'attente de traduction aura rattrapé son retard.

§1 Résumé

  • Composite fair value $47 with high case $71.
  • Implied downside of 78.8% to fair value.
  • Moat 9/10 · confidence 82/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$47
Margin of safety
-370.7%
Confidence
82/100
Moat
9/10

Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.

$223.15Price
Low $29.83
Mid $47.41
High $71.24

ARM trades against a final fair-value range of $29.83-$71.24, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Cycle upside
    AI-driven datacenter buildout accelerates, driving sustained volume and royalty rate hikes across enterprise logic.

§2 Cas baissier

ARM's valuation is dependent on unblemished execution and perpetual terminal dominance. Any miss in the v9 transition or margin deterioration due to skyrocketing SBCStock-based compensationThe fair-value cost of equity awards (options, RSUs, performance shares) granted to employees. A real economic expense even though it is non-cash. will brutally expose the extreme trailing valuation premium, forcing a vicious multiple contraction.

Comment cette thèse peut échouer

RISC-V Commoditization

· Medium

RISC-V architectures mature rapidly and are heavily adopted by major hyperscalers, structurally destroying ARM's pricing power and triggering a terminal multiple collapse.

FV impact
Severe downside (-80%+)
Trigger
3-5 years

Hyperscaler Silicon Pivot

· Low

Major cloud providers completely internalize logic design without ARM IP, causing a permanent loss of highest-margin datacenter revenue growth assumptions.

FV impact
Material multiple compression
Trigger
2-4 years

Macro Capex Freeze

· High

A macroeconomic recession halts the AI datacenter hardware cycle, delaying the v9 transition and exposing the extreme trailing valuation premium to a rapid de-rating.

FV impact
Immediate -60% price reversion
Trigger
1-2 years
Signaux d'alerte précoce à surveiller
MétriqueActuelSeuil de déclenchement
SBC expense continues to vastly exceed Operating Cash Flow.MonitorDeterioration versus the report thesis
Major hyperscaler announces full pivot to RISC-V architecture.MonitorDeterioration versus the report thesis
Deceleration in v9 royalty rate adoption velocity.MonitorDeterioration versus the report thesis
Terminal multiple compression in the broader semiconductor sector.MonitorDeterioration versus the report thesis
Revenue growth falls below 20% in the near term.MonitorDeterioration versus the report thesis

§3 Historique financier

Compte de résultat — six derniers exercices
PosteT−0T−1T−2T−3T−4TCAC
Période2022-03-312023-03-312024-03-312025-03-312026-03-31Trend
Chiffre d'affaires$2.70B$2.68B$3.23B$4.01B+10.3%
Marge brute$2.57B$2.57B$3.08B$3.89B+10.9%
Résultat d'exploitation$680.0M$678.0M$117.0M$831.0M+5.1%
Résultat net$549.0M$524.0M$306.0M$792.0M+9.6%
BPA (dilué)$0.51$0.29$0.61$0.85+13.6%
EBITDA$865.0M$848.0M$279.0M$1.01B+4.1%
R&D$995.0M$1.13B$1.98B$2.07B+20.1%
SG&A$897.0M$762.0M$983.0M$984.0M+2.3%

Scores de qualité

OCF / Résultat net
0.5×
>1 indique une qualité élevée des résultats
Seuil de qualité comptable
Fail
Seuil ajusté au secteur
ROIC
9.1%
Rendement du capital investi
§3

Numbers analysis

Flux de trésorerie

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

Allocation du capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Abonnés individuels — à partir de §411 sections supplémentaires

Lire l'analyse complète — 11 sections supplémentaires.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Rapport complet pour chaque action couverte
24 mois d'archives de notations
Briefings de liste de suivi + alertes de changement de notation
Export PDF + DOCX dans n'importe quelle langue
Démarrer l'essai gratuit
Annulable à tout moment.
BALANCE SHEET FAQ

ARM balance sheet questions

  1. ARM (ARM)'s balance sheet section reports total assets, total liabilities, shareholders' equity, and the structure of debt versus cash so leverage and liquidity can be read directly.
FAQ

ARM — frequently asked questions

  1. Based on our latest analysis, ARM looks meaningfully overvalued. The current price is $223 versus a composite fair-value midpoint of $47.4 (range $29.8–$71.2), which implies roughly 78.8% downside to the midpoint.
Related coverage

Names readers of ARM also follow

Same archetype: mature-compounder